Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.600
-0.040 (-1.10%)
May 7, 2026, 11:29 AM EDT - Market open
Sana Biotechnology Employees
Sana Biotechnology had 142 employees as of December 31, 2025. The number of employees decreased by 52 or -26.80% compared to the previous year.
Employees
142
Change (1Y)
-52
Growth (1Y)
-26.80%
Revenue / Employee
n/a
Profits / Employee
-$1,719,479
Market Cap
999.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 142 | -52 | -26.80% | 142 | 0 |
| Dec 31, 2024 | 194 | -134 | -40.85% | 194 | 0 |
| Dec 31, 2023 | 328 | -93 | -22.09% | 328 | 0 |
| Dec 31, 2022 | 421 | 35 | 9.07% | 418 | 3 |
| Dec 31, 2021 | 386 | 121 | 45.66% | 383 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Maravai LifeSciences Holdings | 435 |
| MeiraGTx Holdings | 403 |
| Phathom Pharmaceuticals | 371 |
| Xencor | 260 |
| Geron | 258 |
| ORIC Pharmaceuticals | 104 |
| Annexon | 96 |
| CytomX Therapeutics | 69 |
SANA News
- 1 day ago - Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference - GlobeNewsWire
- 9 days ago - Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - GlobeNewsWire
- 23 days ago - Sana Biotechnology price target raised to $7 from $6 at Wedbush - TheFly
- 23 days ago - Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic - TheFly
- 7 weeks ago - Sana announces follow-up results from first-in-human study transplanting UP421 - TheFly
- 2 months ago - Sana Biotechnology Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 2 months ago - Sana Biotechnology files automatic mixed securities shelf - TheFly
- 2 months ago - Sana Biotechnology reports Q4 EPS (16c), consensus (13c) - TheFly